Ossianix Announces Publication of Positive Preclinical Data on Neutralizing SARS-CoV-2 Infection with a Panel of Single Domain Shark VNAR Antibodies
Ossianix Announces Publication of Positive Preclinical Data on Neutralizing SARS-CoV-2 Infection with a Panel of Single Domain Shark VNAR Antibodies
A highly potent panel of VNARs against the SARS-CoV-2 spike protein has been isolated
Neutralization of SARS-CoV-2 was demonstrated in in vitro infectivity assays
In vitro blocking activities were also found against the N501Y and E484K mutants
Comments are closed.